DOĞANYİĞİT, Z. Et Al. 2023. Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart. Chemical Biology and Drug Design , vol.102, no.5 , 1085-1096.

DOĞANYİĞİT, Z., Okan, A., TAHERİ, S., Yılmaz, Z., Akyüz, E., & Demir, N., (2023). Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart. Chemical Biology and Drug Design , vol.102, no.5, 1085-1096.

DOĞANYİĞİT, ZÜLEYHA Et Al. "Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart," Chemical Biology and Drug Design , vol.102, no.5, 1085-1096, 2023

DOĞANYİĞİT, ZÜLEYHA Et Al. "Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart." Chemical Biology and Drug Design , vol.102, no.5, pp.1085-1096, 2023

DOĞANYİĞİT, Z. Et Al. (2023) . "Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart." Chemical Biology and Drug Design , vol.102, no.5, pp.1085-1096.

@article{article, author={ZÜLEYHA DOĞANYİĞİT Et Al. }, title={Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart}, journal={Chemical Biology and Drug Design}, year=2023, pages={1085-1096} }